BRIDGEWATER, N.J., Nov. 23, 2010 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. ET on Tuesday, November 30 to provide a business update and discuss its third-quarter 2010 financial and operational results.
